Merz Therapeutics to Acquire Two Drugs from Acorda Therapeutics in $185 Million Deal
Merz Therapeutics GmbH, a subsidiary of the Merz Group (Frankfurt/Main), signed an agreement to acquire two marketed drugs from the NASDAQ-listed US company Acorda Therapeutics. The completion of the transaction will “significantly contribute to Merz Therapeutics’ accelerated growth strategy,” the company said. It is the second investment in a NASDAQ company in just over ten … Read more